Use of thianecarboxamides as dgat inhibitors
US7569590B2 · kind B2 · utility
0Cited by
1References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2007 |
| Grant date | Aug 4, 2009 |
| Priority date | — |
| Expiry date | Sep 18, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application describes methods of treating obesity using DGAT-1 inhibitors according to Formula I:including all prodrugs, solvates, pharmaceutically acceptable salts and stereoisomers, wherein R1, R2, R3, R4 and Z are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.